Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3438.95 | 650 / 653 | 99% | 192.27 | 601 / 605 |
adrenal gland | 100% | 2019.48 | 258 / 258 | 97% | 273.57 | 223 / 230 |
brain | 100% | 6497.63 | 2638 / 2642 | 96% | 141.91 | 680 / 705 |
ovary | 96% | 2139.89 | 172 / 180 | 93% | 61.39 | 398 / 430 |
kidney | 99% | 1646.36 | 88 / 89 | 81% | 55.56 | 731 / 901 |
prostate | 82% | 848.51 | 201 / 245 | 95% | 52.37 | 479 / 502 |
pancreas | 66% | 543.86 | 216 / 328 | 71% | 40.00 | 127 / 178 |
uterus | 61% | 815.42 | 103 / 170 | 54% | 33.38 | 248 / 459 |
breast | 43% | 467.12 | 196 / 459 | 59% | 27.44 | 662 / 1118 |
lung | 33% | 335.57 | 192 / 578 | 65% | 41.98 | 756 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 73% | 44.86 | 33 / 45 |
bladder | 10% | 67.52 | 2 / 21 | 60% | 32.00 | 304 / 504 |
skin | 31% | 236.89 | 562 / 1809 | 37% | 14.02 | 175 / 472 |
lymph node | 0% | 0 | 0 / 0 | 66% | 42.42 | 19 / 29 |
spleen | 64% | 525.58 | 154 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 26.66 | 47 / 80 |
stomach | 23% | 168.77 | 84 / 359 | 26% | 10.32 | 73 / 286 |
intestine | 19% | 151.56 | 187 / 966 | 29% | 11.02 | 152 / 527 |
esophagus | 8% | 69.76 | 120 / 1445 | 32% | 13.37 | 59 / 183 |
liver | 0% | 2.54 | 1 / 226 | 37% | 20.25 | 149 / 406 |
heart | 32% | 310.80 | 275 / 861 | 0% | 0 | 0 / 0 |
muscle | 6% | 62.46 | 52 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 6% | 44.18 | 81 / 1335 | 0% | 0 | 0 / 0 |
adipose | 3% | 18.39 | 34 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 5.72 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006915 | Biological process | apoptotic process |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | BEX2 |
Protein name | Protein BEX2 (Brain-expressed X-linked protein 2) (hBex2) Brain expressed X-linked 2 |
Synonyms | |
Description | FUNCTION: Regulator of mitochondrial apoptosis and G1 cell cycle in breast cancer . Protects the breast cancer cells against mitochondrial apoptosis and this effect is mediated through the modulation of BCL2 protein family, which involves the positive regulation of anti-apoptotic member BCL2 and the negative regulation of pro-apoptotic members BAD, BAK1 and PUMA . Required for the normal cell cycle progression during G1 in breast cancer cells through the regulation of CCND1 and CDKN1A . Regulates the level of PP2A regulatory subunit B and PP2A phosphatase activity . In absence of reductive stress, acts as a pseudosubstrate for the CRL2(FEM1B) complex: associates with FEM1B via zinc, thereby preventing association between FEM1B and its substrates (By similarity). . |
Accessions | ENST00000449185.1 ENST00000372677.8 [Q9BXY8-1] X6RDN0 Q9BXY8 ENST00000372674.5 [Q9BXY8-1] ENST00000536889.1 [Q9BXY8-2] |